SCHEMBL13523220

SCHEMBL13523220

Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(C)c34)cc2)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.81
KIT P10721 10/20 0.81
FLT3 P36888 9/20 0.81
FLT1 P17948 6/20 0.81
FLT4 P35916 6/20 0.81
CSF1R P07333 5/20 0.81
LCK P06239 3/20 0.81
LYN P07948 3/20 0.81
BLK P51451 3/20 0.81
FYN P06241 2/20 0.81
SRC P12931 2/20 0.81
ABL1 P00519 1/20 0.81
AURKA O14965 3/20 0.63
ROCK2 O75116 3/20 0.63
RPS6KB1 P23443 3/20 0.63
RPS6KA3 P51812 3/20 0.63
STK3 Q13188 3/20 0.63
ROCK1 Q13464 3/20 0.63
AURKB Q96GD4 3/20 0.63
FGFR1 P11362 3/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233874 0.90 KDR (1.00) KDRKITFLT3FLT1FLT4
SCHEMBL13523218 0.84 KDR (0.82) KDRKITFLT3FLT1FLT4
SCHEMBL419365 0.77 KDR (1.00) KDRKITFLT3FLT1FLT4
SCHEMBL1703478 0.77 KDR (1.00) KDRKITFLT3FLT1FLT4
SCHEMBL13209956 0.77 KDR (0.80) KDRKITFLT3FLT1FLT4
SCHEMBL13523213 0.74 KDR (0.81) KDRKITFLT3FLT1FLT4
SCHEMBL1702898 0.74 KDR (1.00) KDRKITFLT3FLT1FLT4
SCHEMBL424914 0.74 KDR (0.78) KDRKITFLT3FLT1FLT4
SCHEMBL1703142 0.74 KDR (1.00) KDRKITFLT3FLT1FLT4
SCHEMBL1702794 0.74 KDR (1.00) KDRKITFLT3FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004306-A1 PIGF-1 Assay and kits and components thereof ABBOTT LABORATORIES (US) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004306-A1 PIGF-1 Assay and kits and components thereof PGF, FLT1, HDGF KDR 9/4885KIT 140/4885FLT3 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.